Pancreatic Cancer Research

ResearcherNational Center for Global Health and MedicineActive in the last 2 years

Yuya Hisada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0934-8690; OpenAlex author ID A5055616979. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 3 papers · 2023: 1 paper · 2024: 1 paper

Papers 6

  1. Identifying predictors for comorbidities related mortality versus pancreatic cancer related mortality in patients with intraductal papillary mucinous neoplasm. Co-author DOI 10.1002/ueg2.12540↗
  2. Fine-needle biopsy with 19G needle is effective in combination with endoscopic ultrasound-guided tissue acquisition for genomic profiling of unresectable pancr… Co-author DOI 10.1111/den.14423↗
  3. Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System … Co-author DOI 10.1007/s00535-022-01926-z↗
  4. Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study. Co-author DOI 10.1053/j.gastro.2022.03.054↗
  5. Endoscopic duodenal stent placement versus gastrojejunostomy for unresectable pancreatic cancer patients with duodenal stenosis before introduction of initial … Co-author DOI 10.1093/jjco/hyab194↗
  6. Effect of low-dose aspirin use on pancreatic cancer development and morphological changes on imaging in IPMN: A long-term cohort study. Co-author DOI 10.1177/2050640617693524↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Naoyoshi Nagata · 3 shared papers, 2017–2024 · strength 0.36
  2. Katsunori Sekine · 3 shared papers, 2017–2024 · strength 0.36
  3. Naomi Uemura · 3 shared papers, 2017–2024 · strength 0.36
  4. Chigusa Morizane · 3 shared papers, 2022–2023 · strength 0.35
  5. Takashi Kawai · 2 shared papers, 2022–2024 · strength 0.30
  6. Takao Itoi · 2 shared papers, 2022–2024 · strength 0.30
  7. Susumu Hijioka · 2 shared papers, 2022–2023 · strength 0.24
  8. Hidetoshi Kitamura · 2 shared papers, 2022–2023 · strength 0.24
  9. Kotaro Takeshita · 2 shared papers, 2022–2023 · strength 0.24
  10. Akihiro Ohba · 2 shared papers, 2022–2023 · strength 0.24
  11. Hideki Ueno · 2 shared papers, 2022–2023 · strength 0.24
  12. Shota Harai · 2 shared papers, 2022–2023 · strength 0.24
  13. Go Ikeda · 2 shared papers, 2022–2023 · strength 0.24
  14. Takuji Okusaka · 2 shared papers, 2022–2023 · strength 0.24
  15. Yasushi Yatabe · 2 shared papers, 2022–2023 · strength 0.24
  16. Shuntaro Mukai · 1 shared paper, 2024 · strength 0.19
  17. Kenjiro Yamamoto · 1 shared paper, 2024 · strength 0.19
  18. Katsuhiko Iwakiri · 1 shared paper, 2023 · strength 0.13
  19. Daiki Yamashige · 1 shared paper, 2023 · strength 0.13
  20. Nobuyoshi Hiraoka · 1 shared paper, 2023 · strength 0.13
  21. Nobuaki Azemoto · 1 shared paper, 2022 · strength 0.11
  22. Akinori Asagi · 1 shared paper, 2022 · strength 0.11
  23. Yoshinori Ohno · 1 shared paper, 2022 · strength 0.11
  24. Akiko Tsujimoto · 1 shared paper, 2022 · strength 0.11
  25. Hiroaki Yanagimoto · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.